Abstract
Novel antitumor drug methotrexate (MTX) and fluorescence photosensitizer pyropheophorbide-a (PPa) conjugated multifunctional magnetic fluorescence nanoparticles Fe3O4@SiO2–NH2@MTX@PPa (MFMTXPPa) were designed and prepared for chemotherapy, photodynamic therapy (PDT) and medical fluorescence imaging. Fe3O4@SiO2–NH2 nanoparticles were firstly synthesized by a sol–gel process. Then methotrexate and pyropheophorbide-a were successively anchored on the surface of core–shell Fe3O4@SiO2–NH2 nanoparticles via covalently imide bond. The phase structure, composition, morphology, zeta potential, magnetic properties of nanoparticles were characterized by X-ray powder diffraction, Fourier transform infrared spectrometer, transmission electron microscopy, zeta potential, vibration sample magnetometer, thermogravimetric analysis, respectively. Meanwhile, we studied the effect of pH and different polar solvents on the absorption and fluorescence spectrum of MFMTXPPa. Our results indicated that MFMTXPPa preferentially aggregated in the acidic conditions but maintained monomeric form in alkaline conditions. Aggregations exhibit markedly influence on the absorbance and fluorescence intensity. In addition, we found that MFMTXPPa has high magnetization (46.7 emu/g), good water-solubility and dispersity in polar solvents, strong fluorescence intensity in near neutral conditions, and excellent stability in the acid-base system, which may be a potential candidate in the field of chemotherapy, PDT and fluorescence imaging.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.